4//SEC Filing
Diffusion Pharmaceuticals Inc. 4
Accession 0001437749-17-000152
$CRVOCIK 0001053691operating
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 4:15 PM ET
Size
5.4 KB
Accession
0001437749-17-000152
Insider Transaction Report
Form 4
Byrne Thomas E
General Counsel
Transactions
- Award
Stock Option (Right to Buy)
2017-01-03+4,673→ 4,673 totalExercise: $2.26Exp: 2027-01-03→ Common Stock (4,673 underlying)
Footnotes (1)
- [F1]The shares underlying the options vest in equal parts on the last calendar day of each month until fully vested on December 31, 2019.
Documents
Issuer
Diffusion Pharmaceuticals Inc.
CIK 0001053691
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001053691
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 4:15 PM ET
- Size
- 5.4 KB